查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1124864

囊狀纖維化症的全球市場(2022年～2030年):佔有率，規模，趨勢，產業分析報告，醫藥品分類，各給藥途徑，各流通管道，各地區的市場區隔預測

Cystic Fibrosis Market Share, Size, Trends, Industry Analysis Report, By Drug Class (CFTR Modulators, Mucolytics, Bronchodilators, Pancreatic Enzyme Supplements), Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

全球囊狀纖維化症的市場規模在2030年前將達到370億4,000萬美元。

這份報告提供全球囊狀纖維化症市場調查，提供市場概要，市場的推動因素與阻礙因素的分析，市場機會，COVID-19影響，各市場區隔的市場分析，競爭情形，主要企業的簡介等系統性資訊。

目錄

第1章 簡介

  • 報告的說明
    • 調查的目的
    • 市場範圍
    • 假設
  • 利害關係者

第2章 摘要整理

  • 市場概況

第3章 調查手法

  • 概要
    • 資料探勘
  • 資料資訊來源
    • 一級資訊來源
    • 二級資訊來源

第4章 囊狀纖維化症的全球市場:洞察

  • 產業的概述
  • 市場動態
    • 促進因素和機會
    • 阻礙因素與課題
  • 波特的五力分析
    • 供給企業談判力(中)
    • 新加入廠商者的威脅(低)
    • 買方議價能力(中)
    • 替代威脅(中)
    • 現有企業間的競爭(高)
  • 大環境分析
  • 產業趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 囊狀纖維化症的全球市場:醫藥品分類

  • 主要調查結果
  • 簡介
    • 全球囊狀纖維化症市場(2018年～2030年):醫藥品分類
  • CFTR調製器
    • 各地區的囊狀纖維化症的全球市場:CFTR調製器
  • 粘液溶解劑
    • 各地區的囊狀纖維化症的全球市場:粘液溶解劑各
  • 支氣管擴張藥
    • 各地區的囊狀纖維化症的全球市場:支氣管擴張藥
  • 胰酵素補充品
    • 各地區的囊狀纖維化症的全球市場:胰臟酵素補充品
  • 其他
    • 各地區的囊狀纖維化症的全球市場:其他

第6章 囊狀纖維化症的全球市場:各給藥途徑

  • 主要調查結果
  • 簡介
    • 全球囊狀纖維化症市場(2018年～2030年):各給藥途徑
  • 口服藥
    • 各地區的囊狀纖維化症的全球市場:口服藥
  • 非口服藥
    • 各地區的囊狀纖維化症的全球市場:非口服藥

第7章 囊狀纖維化症的全球市場:各流通管道

  • 主要調查結果
  • 簡介
    • 囊狀纖維化症的全球市場(2018年～2030年):各流通管道
  • 醫院
    • 各地區的囊狀纖維化症的全球市場:醫院
  • 零售藥局
    • 各地區的囊狀纖維化症的全球市場:零售藥局
  • 其他
    • 各地區的囊狀纖維化症的全球市場:其他

第8章 囊狀纖維化症的全球市場:各地區

  • 主要調查結果
  • 簡介
    • 囊狀纖維化症市場評估:各地區(2018年～2030年)
  • 北美
    • 醫藥品分類
    • 各流通管道
    • 各給藥途徑
    • 美國
    • 加拿大
  • 歐洲
    • 醫藥品分類
    • 各流通管道
    • 各給藥途徑
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 醫藥品分類
    • 各流通管道
    • 各給藥途徑
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東及非洲
    • 醫藥品分類
    • 各流通管道
    • 各給藥途徑
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 南美
    • 醫藥品分類
    • 各流通管道
    • 各給藥途徑
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 夥伴關係/合作/協定/展示會

第10章 企業簡介

  • Vertex Pharmaceutical Incorporated
  • Teva Pharmaceuticals
  • AbbVie
  • Viatris Inc
  • Genentech Inc
  • Novartis AG
  • Mylan N.V
  • Pfizer Inc
  • BayerAG
  • Astrazeneca
  • Gilead Sciences
  • Nestle Health Science
  • Chiesi Farmacrutici
  • Roche
  • Pharmaxis Ltd
  • Horizon Therapeutic Plc
Product Code: PM1325

Cystic Fibrosis Market size is expected to reach USD 37.04 billion by 2030, according to a new study by 24.3% Market Research. The report "Cystic Fibrosis Market Share, Size, Trends, Industry Analysis Report, By Drug Class (CFTR Modulators, Mucolytics, Bronchodilators, Pancreatic Enzyme Supplements), Route of Administration {Oral Drugs, Inhaled drugs}, By Distribution Channel, By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising awareness about cystic fibrosis and growing adoption of drug therapies are the prominent factors driving the cystic fibrosis market growth. A variety of oral and inhaled drugs are available for the treatment that increases compliance to the treatment owing to the ease and convenience of administering it. The widespread availability of different cystic fibrosis treatment options will expand the market size over the coming years.

Cystic fibrosis is a genetic disorder that affects more than 30,000 people in the U.S. and over 70,000 people are suffering from it worldwide. Additionally, more than approximately 1000 new cases of the disease are diagnosed every year.

Favorable technological advancements in this therapeutic area will open new avenues of growth for industry participants. Rising innovation in the development of new therapies and drug products to cure cystic fibrosis is anticipated to foster growth in the cystic fibrosis market over the analysis period.

Rising number of cases of respiratory illness post Covid-19 pandemic has spurred the cystic fibrosis market growth. It has given the key industry players an opportunity to focus on the development of new drugs that can enable fast recovery and reduce mortality rates across the globe.

High cost of treatment, stringent regulations prolong approval of drugs, and adverse effects of currently available drugs such as liver problems, upper respiratory tract infection, chest pain, and increased blood pressure among others will hinder the future market growth.

Cystic Fibrosis Market Report Highlights

CFTR modulators segment is anticipated to grow at a significant CAGR over the forecast period owing to their efficacy in improving body function at the cellular level and positively impact the quality of life.

Oral drugs accounted for a significant share owing to the preference among patients and medical practitioners due to the ease and convenience associated with administering the cystic fibrosis drugs

Hospital segment is expected to hold a significant market share among the distribution channels over the forecast period owing to the rising need for precise diagnosis and required medical supervision associated with the treatment. Moreover, the rising number of patient hospital visits will fuel the hospital segment growth.

North America is expected to grow at a significant CAGR over the projected period on account of the increasing incidence of cystic fibrosis and the availability of multiple treatment options in the region.

Global players include Vertex Pharmaceutical, Genentech Inc., Teva Pharmaceuticals, Gilead Sciences, Roche, Nestle Health Science, AbbVie, Vitric Inc., Novartis AG, Mylan N.V, Pfizer Inc., Bayer, AstraZeneca, and Horizon Therapeutic, among others.

Polaris Market Research has segmented the cystic fibrosis market report based on drug class, route of administration, distribution channel, and region:

Cystic Fibrosis Market, By Drug Class (Revenue - USD Billion, 2018 - 2030)

CFTR modulators

Mucolytics

Bronchodilators

Pancreatic enzyme supplements

Others

Cystic Fibrosis Market, By Route of Administration (Revenue - USD Billion, 2018 - 2030)

Oral drugs

Parenteral drugs

Cystic Fibrosis Market, By Distribution Channel (Revenue - USD Billion, 2018 - 2030)

Hospital

Retail pharmacies

Others

Cystic Fibrosis Market, By Region (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cystic Fibrosis Market Insights

  • 4.1. Cystic Fibrosis - Industry Snapshot
  • 4.2. Cystic Fibrosis Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rise in incidence of cystic fibrosis (CF)
      • 4.2.1.2. Advancements in therapeutics for the treatment of cystic fibrosis
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Low awareness in developing nations
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cystic Fibrosis Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cystic Fibrosis Market, by Drug Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • 5.3. CFTR modulators
    • 5.3.1. Global Cystic Fibrosis Market, by CFTR modulators, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Mucolytics
    • 5.4.1. Global Cystic Fibrosis Market, by Mucolytics, by Region, 2018 - 2030 (USD Billion)
  • 5.5. Bronchodilators
    • 5.5.1. Global Cystic Fibrosis Market, by Bronchodilators, by Region, 2018 - 2030 (USD Billion)
  • 5.6. Pancreatic enzyme supplements
    • 5.6.1. Global Cystic Fibrosis Market, by Pancreatic enzyme supplements, by Region, 2018 - 2030 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Other Cystic Fibrosis Market, by Region, 2018 - 2030 (USD Billion)

6. Global Cystic Fibrosis Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • 6.3. Oral drugs
    • 6.3.1. Global Cystic Fibrosis Market, by Oral drugs, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Parenteral drugs
    • 6.4.1. Global Cystic Fibrosis Market, by Parenteral drugs, by Region, 2018 - 2030 (USD Billion)

7. Global Cystic Fibrosis Market, by Distribution channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • 7.3. Hospital
    • 7.3.1. Global Cystic Fibrosis Market, by Hospital, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Retail pharmacies
    • 7.4.1. Global Cystic Fibrosis Market, by Retail pharmacies, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Other Cystic Fibrosis Market, by Region, 2018 - 2030 (USD Billion)

8. Global Cystic Fibrosis Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cystic Fibrosis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 8.3. Cystic Fibrosis Market - North America
    • 8.3.1. North America: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
    • 8.3.2. North America: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
    • 8.3.3. North America: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.3.4. Cystic Fibrosis Market - U.S.
      • 8.3.4.1. U.S.: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.3.4.2. U.S.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.3.4.3. U.S.: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.3.5. Cystic Fibrosis Market - Canada
      • 8.3.5.1. Canada: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.3.5.2. Canada.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.3.5.3. Canada: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • 8.4. Cystic Fibrosis Market - Europe
    • 8.4.1. Europe: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
    • 8.4.2. Europe.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
    • 8.4.3. Europe: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.4.4. Cystic Fibrosis Market - UK
      • 8.4.4.1. UK: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.4.4.2. UK.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.4.4.3. UK: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.4.5. Cystic Fibrosis Market - France
      • 8.4.5.1. France: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.4.5.2. France.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.4.5.3. France: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.4.6. Cystic Fibrosis Market - Germany
      • 8.4.6.1. Germany: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.4.6.2. Germany.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.4.6.3. Germany: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.4.7. Cystic Fibrosis Market - Italy
      • 8.4.7.1. Italy: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.4.7.2. Italy.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.4.7.3. Italy: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.4.8. Cystic Fibrosis Market - Spain
      • 8.4.8.1. Spain: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.4.8.2. Spain.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.4.8.3. Spain: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.4.9. Cystic Fibrosis Market - Netherlands
      • 8.4.9.1. Netherlands: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.4.9.2. Netherlands.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.4.9.3. Netherlands: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.4.10. Cystic Fibrosis Market - Russia
      • 8.4.10.1. Russia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.4.10.2. Russia.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.4.10.3. Russia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • 8.5. Cystic Fibrosis Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
    • 8.5.2. Asia Pacific.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
    • 8.5.3. Asia Pacific: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.5.4. Cystic Fibrosis Market - China
      • 8.5.4.1. China: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.5.4.2. China.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.5.4.3. China: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.5.5. Cystic Fibrosis Market - India
      • 8.5.5.1. India: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.5.5.2. India.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.5.5.3. India: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.5.6. Cystic Fibrosis Market - Malaysia
      • 8.5.6.1. Malaysia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.5.6.2. Malaysia.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.5.6.3. Malaysia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.5.7. Cystic Fibrosis Market - Japan
      • 8.5.7.1. Japan: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.5.7.2. Japan.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.5.7.3. Japan: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.5.8. Cystic Fibrosis Market - Indonesia
      • 8.5.8.1. Indonesia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.5.8.2. Indonesia.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.5.8.3. Indonesia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.5.9. Cystic Fibrosis Market - South Korea
      • 8.5.9.1. South Korea: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.5.9.2. South Korea.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.5.9.3. South Korea: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • 8.6. Cystic Fibrosis Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
    • 8.6.2. Middle East & Africa.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
    • 8.6.3. Middle East & Africa: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.6.4. Cystic Fibrosis Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.6.5. Cystic Fibrosis Market - UAE
      • 8.6.5.1. UAE: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.6.5.2. UAE.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.6.5.3. UAE: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.6.6. Cystic Fibrosis Market - Israel
      • 8.6.6.1. Israel: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.6.6.2. Israel.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.6.6.3. Israel: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.6.7. Cystic Fibrosis Market - South Africa
      • 8.6.7.1. South Africa: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.6.7.2. South Africa.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.6.7.3. South Africa: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • 8.7. Cystic Fibrosis Market - Latin America
    • 8.7.1. Latin America: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
    • 8.7.2. Latin America.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
    • 8.7.3. Latin America: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.7.4. Cystic Fibrosis Market - Mexico
      • 8.7.4.1. Mexico: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.7.4.2. Mexico.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.7.4.3. Mexico: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.7.5. Cystic Fibrosis Market - Brazil
      • 8.7.5.1. Brazil: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.7.5.2. Brazil.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.7.5.3. Brazil: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 8.7.6. Cystic Fibrosis Market - Argentina
      • 8.7.6.1. Argentina: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
      • 8.7.6.2. Argentina.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
      • 8.7.6.3. Argentina: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Vertex Pharmaceutical Incorporated
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Teva Pharmaceuticals
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. AbbVie
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Viatris Inc
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Genentech Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Novartis AG
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mylan N.V
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Pfizer Inc
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. BayerAG
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Astrazeneca
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Gilead Sciences
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Nestle Health Science
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Chiesi Farmacrutici
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Roche
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Pharmaxis Ltd
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. Horizon Therapeutic Plc
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development

List of Tables

  • Table 1 Global Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 2 Global Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 3 Global Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 4 Cystic Fibrosis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 5 North America: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 6 North America: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 7 North America: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 8 U.S.: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 9 U.S.: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 10 U.S.: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 11 Canada: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 12 Canada: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 13 Canada: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 14 Europe: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 15 Europe: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 16 Europe: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 17 UK: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 18 UK: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 19 UK: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 20 France: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 21 France: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 22 France: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 23 Germany: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 24 Germany: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 25 Germany: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 26 Italy: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 27 Italy: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 28 Italy: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 29 Spain: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 30 Spain: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 31 Spain: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 32 Netherlands: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 33 Netherlands: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 34 Netherlands: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 35 Russia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 36 Russia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 37 Russia: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 38 Asia Pacific: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 39 Asia Pacific: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 40 Asia Pacific: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 41 China: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 42 China: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 43 China: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 44 India: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 45 India: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 46 India: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 47 Malaysia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 48 Malaysia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 49 Malaysia: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 50 Japan: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 51 Japan: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 52 Japan: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 53 Indonesia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 54 Indonesia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 55 Indonesia: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 56 South Korea: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 57 South Korea: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 58 South Korea: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 59 Middle East & Africa: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 60 Middle East & Africa: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 61 Middle East & Africa: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 62 Saudi Arabia: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 63 Saudi Arabia: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 64 Saudi Arabia: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 65 UAE: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 66 UAE: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 67 UAE: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 68 Israel: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 69 Israel: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 70 Israel: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 71 South Africa: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 72 South Africa: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 73 South Africa: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 74 Latin America: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 75 Latin America: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 76 Latin America: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 77 Mexico: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 78 Mexico: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 79 Mexico: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 80 Brazil: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 81 Brazil: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 82 Brazil: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)
  • Table 83 Argentina: Cystic Fibrosis Market, by Drug Class, 2018 - 2030 (USD Billion)
  • Table 84 Argentina: Cystic Fibrosis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 85 Argentina: Cystic Fibrosis Market, by Distribution channel, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Cystic Fibrosis Market, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Approach

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Route of Administration

Figure 7. Global Cystic Fibrosis Market, by Route of Administration, 2021 & 2030 (USD Billion)

Figure 8. Market by Drug Class

Figure 9. Global Cystic Fibrosis Market, by Drug Class, 2021 & 2030 (USD Billion)

Figure 10. Market by Distribution channel

Figure 11. Global Cystic Fibrosis Market, by Distribution channel, 2021 & 2030 (USD Billion)

Figure 12. Cystic Fibrosis Market Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 13. Strategic Analysis - Cystic Fibrosis Market